OmniVision AG is a Originators company based in Neuhausen am Rheinfall (Schaffhausen) recorded by Swissmedic as the authorisation holder for 32 human medicines. That places it 52 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Originators |
|---|---|
| City | Neuhausen am Rheinfall |
| Canton | Schaffhausen |
| Authorisation holder | Yes |
| Medicines | 32 |
| Founded | Not available |
| Employees | 11-50 |
| Parent group | OmniVision GmbH |
| Activity | Not available |
| Website | omnivision.ch |
Medicines authorised in Switzerland
OmniVision AG is recorded by Swissmedic as the authorisation holder for 32 human medicines. The table shows 32 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
32 of 32 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| AciVision 30 mg/g | 68800 | A | S01AD03 | 2023-01-23 |
| Aflivis 40 mg/ml | 70061 | B | S01LA05 | 2026-02-02 |
| Aflivis 40 mg/ml | 70062 | B | S01LA05 | 2026-02-02 |
| Allergo-Vision SDU 0.25 mg/ml | 68345 | B | - | 2022-06-15 |
| BimatoTim-Vision SDU 0 | 70220 | B | S01ED51 | 2026-06-29 |
| Brimo-Vision 2 mg/ml | 67312 | B | S01EA05 | 2020-03-25 |
| Brinzo-Vision 10 mg/ml | 70749 | B | S01EC04 | 2026-07-14 |
| Dorzo-Vision 2 % | 62671 | B | S01EC03 | 2012-10-11 |
| DorzoComp-Vision 20mg/ml / 5mg/ml | 65629 | B | S01ED51 | 2016-04-07 |
| DorzoComp-Vision SDU 20 mg/ml + 5mg/ml | 69149 | B | S01ED51 | 2023-06-08 |
| Fluoresceine Oxybuprocaine SDU Faure | 54756 | B | S01JA51 | 1999-01-11 |
| Glaupax | 38412 | B | S01EC01 | 1975-01-13 |
| KetoVision | 61219 | B | S01BC05 | 2011-07-27 |
| Lacri-Vision | 66942 | B | S01XA20 | 2018-10-25 |
| Latano-Vision | 62295 | B | S01EE01 | 2012-02-28 |
| Latano-Vision SDU 50 μg/ml | 69723 | B | S01EE01 | 2024-08-22 |
| LatanoTim-Vision | 62696 | B | S01ED51 | 2013-02-13 |
| LatanoTim-Vision SDU 50 µg / ml + 5 mg / ml | 70651 | B | S01ED51 | 2026-05-26 |
| Mydriaticum Dispersa | 23855 | B | S01FA06 | 1957-10-18 |
| NaCl 5 % Dispersa | 47039 | B | S01XA03 | 1986-03-17 |
| Novesin 0 | 36289 | B | S01HA02 | 1971-03-01 |
| Scopolamine 0 | 29804 | B | S01FA02 | 1963-10-08 |
| Spersacarpine 2 % | 26073 | B | S01EB01 | 1960-07-01 |
| Spersadex mono 0.1% | 31069 | A | S01BA01 | 1964-11-24 |
| Spersapolymyxin | 36290 | A | S01AA30 | 1971-03-15 |
| Travo-Vision 40mcg/ml | 66505 | B | S01EE04 | 2017-09-28 |
| Travo-Vision SDU 40 ug / ml | 69430 | B | S01EE04 | 2023-12-01 |
| TravoTim-Vision | 67232 | B | S01ED51 | 2020-04-24 |
| Voltaren Ophtha CD | 55864 | B | - | 2002-05-15 |
| Voltaren Ophtha SDU | 52757 | B | - | 1994-06-06 |
| Zaditen Ophtha | 55341 | B | S01GX08 | 2000-05-05 |
| Zaditen Ophtha SDU | 55342 | B | S01GX08 | 2000-05-05 |
Frequently asked questions
How many medicines does OmniVision AG have authorised in Switzerland?
OmniVision AG is recorded by Swissmedic as the authorisation holder for 32 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is OmniVision AG based?
The Swiss location recorded for OmniVision AG is Neuhausen am Rheinfall, Schaffhausen.
Is OmniVision AG a Swissmedic authorisation holder?
Yes. OmniVision AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.